Your browser doesn't support javascript.
loading
Corrigendum to "CD4+ T cells and TGFß1/MAPK signal pathway involved in the valvular hyperblastosis and fibrosis in patients with rheumatic heart disease" [Experimental and Molecular Pathology 114 (2020) 104402].
Zhao, Zhiwei; He, Danqing; Ling, Fei; Chu, Tianshu; Huang, Dake; Wu, Huaxun; Ge, Jianjun.
  • Zhao Z; Department of Cardiovascular Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, Anhui 230001, China. Electronic address: zzw20190000@163.com.
  • He D; Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China.
  • Ling F; Department of Cardiovascular Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, Anhui 230001, China.
  • Chu T; Department of Cardiovascular Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, Anhui 230001, China.
  • Huang D; Comperhensive Laboratory of Anhui Medical University, Hefei, Anhui 230032, China.
  • Wu H; Institute of Clinical Pharmacology, Anhui Medical University, Hefei, Anhui 230032, China.
  • Ge J; Department of Cardiovascular Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, Anhui 230001, China. Electronic address: zkdgjj@ustc.edu.cn.
Exp Mol Pathol ; 125: 104741, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35124333

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article